Asymmetric dimethylarginine (ADMA) as a novel prognostic factor for survival in hemodialysis patients

Abstract

Asymmetric dimethylarginine, albumin, C-reactive protein and cardiac troponin, predicted overall mortality in hemodialysis patients.

Keywords

• Asymmetric
• dimethylarginine
• novel
• prognostic
• factor
• survival
• hemodialysis
• patients